These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 17904874)
1. Induction of endoreduplication by a JNK inhibitor SP600125 in human lung carcinoma A 549 cells. Miyamoto-Yamasaki Y; Yamasaki M; Tachibana H; Yamada K Cell Biol Int; 2007 Dec; 31(12):1501-6. PubMed ID: 17904874 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of c-Jun-N-terminal-kinase sensitizes tumor cells to CD95-induced apoptosis and induces G2/M cell cycle arrest. Kuntzen C; Sonuc N; De Toni EN; Opelz C; Mucha SR; Gerbes AL; Eichhorst ST Cancer Res; 2005 Aug; 65(15):6780-8. PubMed ID: 16061660 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of JNK reduces G2/M transit independent of p53, leading to endoreduplication, decreased proliferation, and apoptosis in breast cancer cells. Mingo-Sion AM; Marietta PM; Koller E; Wolf DM; Van Den Berg CL Oncogene; 2004 Jan; 23(2):596-604. PubMed ID: 14724588 [TBL] [Abstract][Full Text] [Related]
4. Synergetic and Antagonistic Molecular Effects Mediated by the Feedback Loop of p53 and JNK between Saikosaponin D and SP600125 on Lung Cancer A549 Cells. Chen X; Liu C; Zhao R; Zhao P; Wu J; Zhou N; Ying M Mol Pharm; 2018 Nov; 15(11):4974-4984. PubMed ID: 30207732 [TBL] [Abstract][Full Text] [Related]
5. SP600125 suppresses Cdk1 and induces endoreplication directly from G2 phase, independent of JNK inhibition. Kim JA; Lee J; Margolis RL; Fotedar R Oncogene; 2010 Mar; 29(11):1702-16. PubMed ID: 20062077 [TBL] [Abstract][Full Text] [Related]
6. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo. Hsu YL; Cho CY; Kuo PL; Huang YT; Lin CC J Pharmacol Exp Ther; 2006 Aug; 318(2):484-94. PubMed ID: 16632641 [TBL] [Abstract][Full Text] [Related]
7. Bcl-2 overexpression attenuates SP600125-induced apoptosis in human leukemia U937 cells. Moon DO; Kim MO; Choi YH; Kim ND; Chang JH; Kim GY Cancer Lett; 2008 Jun; 264(2):316-25. PubMed ID: 18343029 [TBL] [Abstract][Full Text] [Related]
8. JNK is constitutively active in mantle cell lymphoma: cell cycle deregulation and polyploidy by JNK inhibitor SP600125. Wang M; Atayar C; Rosati S; Bosga-Bouwer A; Kluin P; Visser L J Pathol; 2009 May; 218(1):95-103. PubMed ID: 19206150 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of cell proliferation and cell cycle progression by specific inhibition of basal JNK activity: evidence that mitotic Bcl-2 phosphorylation is JNK-independent. Du L; Lyle CS; Obey TB; Gaarde WA; Muir JA; Bennett BL; Chambers TC J Biol Chem; 2004 Mar; 279(12):11957-66. PubMed ID: 14704147 [TBL] [Abstract][Full Text] [Related]
10. Novel indoloquinoline derivative, IQDMA, induces G(2)/M phase arrest and apoptosis in A549 cells through JNK/p38 MAPK signaling activation. Su JC; Lin KL; Chien CM; Lu CM; Chen YL; Chang LS; Lin SR Life Sci; 2009 Sep; 85(13-14):505-16. PubMed ID: 19699753 [TBL] [Abstract][Full Text] [Related]
11. Induction of G2/M arrest, endoreduplication, and apoptosis by actin depolymerization agent pextenotoxin-2 in human leukemia cells, involving activation of ERK and JNK. Moon DO; Kim MO; Kang SH; Lee KJ; Heo MS; Choi KS; Choi YH; Kim GY Biochem Pharmacol; 2008 Aug; 76(3):312-21. PubMed ID: 18571148 [TBL] [Abstract][Full Text] [Related]
12. A JNK inhibitor SP600125 induces defective cytokinesis and enlargement in P19 embryonal carcinoma cells. Nakaya K; Ooishi R; Funaba M; Murakami M Cell Biochem Funct; 2009 Oct; 27(7):468-72. PubMed ID: 19711443 [TBL] [Abstract][Full Text] [Related]
13. Growth suppression of human mast cells expressing constitutively active c-kit receptors by JNK inhibitor SP600125. Wang B; Tsukada J; Higashi T; Mizobe T; Matsuura A; Mouri F; Sawamukai N; Ra C; Tanaka Y Genes Cells; 2006 Sep; 11(9):983-92. PubMed ID: 16923120 [TBL] [Abstract][Full Text] [Related]
14. Furano-1,2-naphthoquinone inhibits EGFR signaling associated with G2/M cell cycle arrest and apoptosis in A549 cells. Su JC; Lin KL; Chien CM; Tseng CH; Chen YL; Chang LS; Lin SR Cell Biochem Funct; 2010 Dec; 28(8):695-705. PubMed ID: 21104938 [TBL] [Abstract][Full Text] [Related]
15. Role of p21 in SP600125-induced cell cycle arrest, endoreduplication, and apoptosis. Moon DO; Choi YH; Kim GY Cell Mol Life Sci; 2011 Oct; 68(19):3249-60. PubMed ID: 21311948 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of tumor growth, angiogenesis, and tumor cell proliferation by a small molecule inhibitor of c-Jun N-terminal kinase. Ennis BW; Fultz KE; Smith KA; Westwick JK; Zhu D; Boluro-Ajayi M; Bilter GK; Stein B J Pharmacol Exp Ther; 2005 Apr; 313(1):325-32. PubMed ID: 15626722 [TBL] [Abstract][Full Text] [Related]
17. Decitabine, a DNA methyltransferases inhibitor, induces cell cycle arrest at G2/M phase through p53-independent pathway in human cancer cells. Shin DY; Sung Kang H; Kim GY; Kim WJ; Yoo YH; Choi YH Biomed Pharmacother; 2013 May; 67(4):305-11. PubMed ID: 23582784 [TBL] [Abstract][Full Text] [Related]
18. P53 and p38 MAPK pathways are involved in MONCPT-induced cell cycle G2/M arrest in human non-small cell lung cancer A549. Zhang C; Zhu H; Yang X; Lou J; Zhu D; Lu W; He Q; Yang B J Cancer Res Clin Oncol; 2010 Mar; 136(3):437-45. PubMed ID: 19727814 [TBL] [Abstract][Full Text] [Related]
19. Cordycepin causes p21WAF1-mediated G2/M cell-cycle arrest by regulating c-Jun N-terminal kinase activation in human bladder cancer cells. Lee SJ; Kim SK; Choi WS; Kim WJ; Moon SK Arch Biochem Biophys; 2009 Oct; 490(2):103-9. PubMed ID: 19733546 [TBL] [Abstract][Full Text] [Related]
20. Involvement of c-Jun N-terminal kinase in G2/M arrest and FasL-mediated apoptosis induced by a novel indoloquinoline derivative, IQDMA, in K562 cells. Yang SH; Chien CM; Lu CM; Chen YL; Chang LS; Lin SR Leuk Res; 2007 Oct; 31(10):1413-20. PubMed ID: 17397922 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]